ADC THERAPEUTICS SA
ADCT · NYSE
Updated at 2026-10-14 09:06:44
- Today's High
- $1.86
- Today’s Low
- $1.62
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.70
- Previous Close
- $1.86
- Volume
- 1.59M
- Market Cap
- $237.46M
- P/E Ratio
- --
- EPS
- $-0.72
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- BIOPOLE, EPALINGES, SWITZERLAND, 1066
- Country
- CH
- Listing Date
- 2020-05-15
- Fiscal Year End
- December
- Shares Outstanding
- 127.19M
- CIK
- 0001771910
- Website
- adctherapeutics.com
ADC Therapeutics SA, a biotechnology company focused on clinical stage oncology, develops Antibody Drug Conjugates (ADC) for patients suffering from hematologic malignancies and solid tumors. The company is headquartered in Epalinges, Switzerland.
Financial Metrics
Revenue
2026-06-30
$19.24M
2026-03-31
$20.03M
2025-12-31
$23.05M
2025-09-30
$16.42M
Operating Expenses
2026-06-30
$42.31M
2026-03-31
$41.66M
2025-12-31
$39.48M
2025-09-30
$45.55M
Net Income
2026-06-30
-$16.56M
2026-03-31
-$32.96M
2025-12-31
-$6.4M
2025-09-30
-$40.96M
Net Profit Margin
2026-06-30
-86.06%
2026-03-31
-164.56%
2025-12-31
-27.79%
2025-09-30
-249.38%
Earnings Per Share
2026-06-30
$-0.11
2026-03-31
$-0.21
2025-12-31
$-0.04
2025-09-30
$-0.30
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$45.95M
2026-03-31
-$20.5M
2025-12-31
$6.31M
2025-09-30
-$27.45M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
5.92%
2025-09-30
0.64%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $19.24M | $20.03M | $23.05M | $16.42M |
| Operating Expenses | $42.31M | $41.66M | $39.48M | $45.55M |
| Net Income | -$16.56M | -$32.96M | -$6.4M | -$40.96M |
| Net Profit Margin | -86.06% | -164.56% | -27.79% | -249.38% |
| Earnings Per Share | $-0.11 | $-0.21 | $-0.04 | $-0.30 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$45.95M | -$20.5M | $6.31M | -$27.45M |
| Effective Tax Rate | -- | -- | 5.92% | 0.64% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.